Issa; Issa; Abdel-Latif, Journal of the Indian Chemical Society, 1997, vol. 74, # 9, p. 731 - 733
作者:Issa、Issa、Abdel-Latif、Abdel-Salam
DOI:——
日期:——
ROLLAS, SEVIM;BUYUKTIMKIN, SERVET;BUYUKTIMKIN, N.;ULGEN, M.;YEMNI, E., PHARMAZIE, 43,(1988) N 7, C. 511
作者:ROLLAS, SEVIM、BUYUKTIMKIN, SERVET、BUYUKTIMKIN, N.、ULGEN, M.、YEMNI, E.
DOI:——
日期:——
TARGETED CORRECTION OF A GENETIC DEFECT IN CANCER THERAPY
申请人:TRT Pharma Inc.
公开号:US20130143933A1
公开(公告)日:2013-06-06
The present document describes a cancer mutation-selective chemosensitizer that comprise compounds for restoring association between mutated keap1 protein and Nrf2 protein, and inhibition of Nrf2 functions. The present document also describes composition of matter containing the compounds, as well as methods of medical treatment for treating diseases such as cancer with the compounds.